Fundz

SpectaCell raises €6M in seed funding for immune therapy testing platform. Belgian life sciences company backed by imec.xpand and strategic investors.

PRIVATEOct 09, 2026

Amount Raised

$6.7 Million

Round Type

Seed

BelgiumBiotechnologyHealth Care

Investors

VibQbicImec.XpandPMV Flanders Future Tech FundInnovationQuarter Capital

Description

SpectaCell, a Belgian life sciences company spun out of imec, VIB, and Ghent University, has secured €6 million ($6.7 million) in seed financing. The round was led by venture capital investor imec.xpand, with participation from PMV's Flanders Future Tech Fund, InnovationQuarter Capital, Qbic, and VIB. The funding will support the development of a cell analysis platform designed to help pharmaceutical companies assess immune therapies from early research through manufacturing.

Quick answer

SpectaCell raised $6.7 Million in a Seed round, dated October 9, 2026. Investors: Vib, Qbic, Imec.Xpand, PMV Flanders Future Tech Fund and InnovationQuarter Capital. SpectaCell is based in Belgium.

How much did SpectaCell raise?
SpectaCell raised $6.7 Million in a Seed round on October 9, 2026.
Who invested in SpectaCell?
Vib, Qbic, Imec.Xpand, PMV Flanders Future Tech Fund and InnovationQuarter Capital are named as investors in this round.
What does SpectaCell do?
SpectaCell is a Belgian life sciences company spun out of research organizations imec, VIB, and Ghent University.
Where is SpectaCell based and how big is it?
SpectaCell is based in Belgium. Fundz records about 4 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as SpectaCell that raised within 45 days of this round, from Fundz verified event records.

  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
  • Neurosterix raised $105M (Series B) on November 11, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.

Who to call at SpectaCell, and when

A new round usually means SpectaCell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SpectaCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SpectaCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SpectaCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SpectaCell

Location

Belgium

About

SpectaCell is a Belgian life sciences company spun out of research organizations imec, VIB, and Ghent University. It develops a cell analysis platform designed to help drugmakers assess immune therapies from early research through manufacturing. The company focuses on immune therapy testing and evaluation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SpectaCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SpectaCell's next move

See what Strategic adds

SpectaCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.